Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 39.00M | £ 34.00M | £ 68.20M | £ 4.70M | £ 39.80M |
Total Assets | £ 1.07B | £ 1.06B | £ 1.00B | £ 997.50M | £ 1.02B |
Total Debt | £ 207.10M | £ 207.80M | £ 208.50M | £ 253.40M | £ 243.60M |
Net Debt | £ 168.10M | £ 173.80M | £ 140.30M | £ 248.70M | £ 203.80M |
Total Liabilities | £ 361.40M | £ 362.20M | £ 350.60M | £ 352.10M | £ 369.80M |
Stockholders Equity | £ 708.10M | £ 699.70M | £ 652.80M | £ 645.40M | £ 648.90M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |